News & Events
Events 2009
December -10-12th
SABCS (San Antonio Breast Cancer Symposium) - Henry B Gonzalez Convention Center- Booth 335
News
Press Releases
February 19, 2010
GENOPTIX AND HISTORX ANNOUNCE LICENSING AGREEMENT FOR AQUA® TECHNOLOGY
January 19, 2010
HistoRx Names Dick Carroll, Ph.D. as VP of Clinical Research
December 3, 2009
Protein Markers Predict Risk of Melanoma Recurrence
November 17, 2009
AQUA® Technology Recognized as "Promising New Strategy" for Hormone Receptor Testing in Breast Cancer by NCCN Task Force
September 9, 2009
Aperio Partners with HistoRx to Provide Integrated Fluorescence Whole Slide Imaging System
December 17, 2008
HistoRx Names Kate Adams Vice President, Diagnostics Marketing and Retains Steve Chubb as Strategic Advisor
July 17, 2008
HistoRx Names Bill Sullivan Senior Vice President, Diagnostic Operations
May 29, 2008
HistoRx Announces Expanded Access of AQUA® Technology to 900+ Researchers at Dana-Farber/Harvard Cancer Center
March 26, 2008
HistoRx and Lilly Extend, Expand AQUA® Analysis Partnership
November 27, 2007
HistoRx Names Rana Gupta CEO; Announces Board Changes
October 24, 2007
HistoRx Raises $6.0 Million in Series B Funding to Advance Diagnostic Product Development
September 4, 2007
HistoRx and Radiation Therapy Oncology Group Initiate
Brain Tumor Biomarker Research Partnership
May 16, 2007
HistoRx Announces Issuance of U.S.
Patent Covering Core AQUA® Technology
February 22, 2007
HistoRx AQUA® Technology
Identifies Two Biomarkers
Linked to Lung Cancer Survival
February 15, 2007
HistoRx Installs AQUA® Technology at UCLA School of Medicine
October 24, 2006
HistoRx Announces First Installations of New
Quantitative In Situ Biomarker Analysis Platform
January 31, 2006
HistoRx, Inc. Moves to Advance the Development and Commercialization of New Quantitative Tissue Based Diagnostic Tests
December 21, 2005
More Accurate, Quantitative Method Reported for Linking Biomarker Expression to Patient Outcomes
November 1, 2005
Dr. Ronald M. Lindsay Joins HistoRx Board of Directors
October 13, 2005
HistoRx and Eli Lilly Enter Into
a Collaboration
July 25, 2005
High TRAIL-R2 Expression is Associated With Decreased Breast Cancer Survival
May 2, 2005
HistoRx Moves to State-of-the-Art R&D Complex
February 23, 2005
HistoRx to Unveil HARP™ Program
September 14, 2004
HistoRx Completes Initial Financing